Literature DB >> 9697993

Characterization of the murine immune response to the murine TSH receptor ectodomain: induction of hypothyroidism and TSH receptor antibodies.

H Vlase1, M Weiss, P N Graves, T F Davies.   

Abstract

The thyrotropin receptor (TSHR) is the major autoantigen of human Graves' disease. In order to define the antigenicity of the TSHR in a defined model, we examined the immune response of BALB/c mice to immunization with a new bioactive, recombinant preparation of the ectodomain of the murine TSHR (mTSHR-ecd). Mice (n = 10) were immunized with 25-50 microg of insect cell expressed, purified and refolded, mTSHR-ecd in alum adjuvant containing pertussis toxin, on days 0, 21, 36, 50 and 70. Control mice received wild-type baculovirus-infected insect cell protein lysate, in a similar way. After 28 days, murine serum contained high titres of antibodies specific to mTSH-ecd and their titres continued to increase over 90 days. Antibody epitope mapping, using 26 peptides spanning the human TSHR-ecd, showed that a variety of regions of the ectodomain were antigenic. The earliest epitope included aa 22-41, but later two regions of reactivity were noted clustered towards the mid portion and carboxyl terminus of the ectodomain. The murine TSHR autoantibodies (TSHR-Abs) inhibited up to 78% of the binding of labelled TSH to native TSHR, demonstrating the presence of antibodies capable of blocking the native TSHR. We showed that these TSHR antibodies acted, in vitro, as TSH blocking antibodies, inhibiting TSH-induced generation of cyclic AMP in chinese hamster ovary (CHO) cells transfected with the hTSHR. Hence, the antibody response to mTSHR-ecd was potentially antagonistic in its influence on the TSHR. Assessment of thyroid function in the immunized mice showed a fall in serum total T3 by 90 days and markedly elevated murine TSH levels (from 64.0 to 239.6 ng/ml), confirming the onset of thyroid failure. However, thyroid histology remained grossly normal. These data demonstrate that mTSHR-ecd is a potent antigen with three major immunogenic regions. The induced mTSHR-Abs blocked TSH action in vivo and reduced murine thyroid function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697993      PMCID: PMC1905026          DOI: 10.1046/j.1365-2249.1998.00622.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1.

Authors:  L Wikström; C Johansson; C Saltó; C Barlow; A Campos Barros; F Baas; D Forrest; P Thorén; B Vennström
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

2.  Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice.

Authors:  S Costagliola; M C Many; M Stalmans-Falys; G Vassart; M Ludgate
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

3.  Induction of hyperthyroxinemia in BALB/C but not in several other strains of mice.

Authors:  N M Wagle; J S Dallas; G S Seetharamaiah; J L Fan; R K Desai; O Memar; S Rajaraman; B S Prabhakar
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

4.  Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.

Authors:  L B Nicholson; H Vlase; P Graves; M Nilsson; J Molne; G C Huang; N G Morgenthaler; T F Davies; A M McGregor; J P Banga
Journal:  J Mol Endocrinol       Date:  1996-04       Impact factor: 5.098

5.  Characterization of soluble, disulfide bond-stabilized, prokaryotically expressed human thyrotropin receptor ectodomain.

Authors:  Y Bobovnikova; P N Graves; H Vlase; T F Davies
Journal:  Endocrinology       Date:  1997-02       Impact factor: 4.736

6.  Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.

Authors:  H Vlase; N Matsuoka; P N Graves; R P Magnusson; T F Davies
Journal:  Endocrinology       Date:  1997-04       Impact factor: 4.736

7.  Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.

Authors:  N Shimojo; Y Kohno; K Yamaguchi; S Kikuoka; A Hoshioka; H Niimi; A Hirai; Y Tamura; Y Saito; L D Kohn; K Tahara
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading.

Authors:  H Vlase; M Nakashima; P N Graves; Y Tomer; J C Morris; T F Davies
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

9.  Folding of the recombinant human thyrotropin (TSH) receptor extracellular domain: identification of folded monomeric and tetrameric complexes that bind TSH receptor autoantibodies.

Authors:  P N Graves; H Vlase; T F Davies
Journal:  Endocrinology       Date:  1995-02       Impact factor: 4.736

10.  Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model.

Authors:  S Costagliola; M C Many; M Stalmans-Falys; M Tonacchera; G Vassart; M Ludgate
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

View more
  2 in total

1.  Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.

Authors:  K Barrett; E Liakata; P V Rao; P F Watson; A P Weetman; P Lymberi; J P Banga; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 2.  Blocking type TSH receptor antibodies.

Authors:  Jadwiga Furmaniak; Jane Sanders; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2012-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.